Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-10 |
mRNA | PARP11 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | ZNF682 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | DYM | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
mRNA | ZNF136 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-10 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-10 |
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-10 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-10 |